You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Everolimus

Showing 1 - 25 of 1,175
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Idiopathic Subglottic Tracheal Stenosis Trial in Baltimore (Everolimus Oral Tablet)

Recruiting
  • Idiopathic Subglottic Tracheal Stenosis
  • Everolimus Oral Tablet
  • Baltimore, Maryland
    Johns Hopkins Outpatient Center
Jul 28, 2022

Epilepsy Trial in Shenyang (Everolimus, Placebo)

Recruiting
  • Epilepsy
  • Everolimus
  • Placebo
  • Shenyang, Liaoning, China
    Shengjing Hospital of China Medical University
Nov 5, 2022

Renal Angiomyolipoma Trial (Everolimus)

Not yet recruiting
  • Renal Angiomyolipoma
  • Everolimus
  • (no location specified)
Aug 15, 2022

Coronary Artery Disease Trial in Fribourg (Implantation of everolimus-eluting bioresorbable vascular scaffold stent,

Completed
  • Coronary Artery Disease
  • Implantation of everolimus-eluting bioresorbable vascular scaffold stent
  • +2 more
  • Fribourg, Switzerland
    Fribourg Cantonal Hospital
Oct 14, 2021

Breast Cancer, Hormone Receptor Positive Tumor Trial in Germany (3 weeks Dose Induction of Everolimus, 3 weeks Conventional

Completed
  • Breast Cancer
  • Hormone Receptor Positive Tumor
  • 3 weeks Dose Induction of Everolimus
  • +3 more
  • Neu Isenburg, Hessen, Germany
  • +13 more
Feb 22, 2022

Percutaneous Coronary Intervention (PCI), Coronary Artery Disease (CAD), De Novo Stenosis Trial in Tunis (DEB for de Novo

Recruiting
  • Percutaneous Coronary Intervention (PCI)
  • +2 more
  • DEB for de Novo Lesions
  • DES for de Novo Lesions
  • Tunis, Tunisia
    Military hospital of Tunis
Aug 23, 2022

Bladder Cancer, Metastatic Transitional Cell Carcinoma Trial in New York (Everolimus)

Completed
  • Bladder Cancer
  • Metastatic Transitional Cell Carcinoma
  • Everolimus
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Dec 16, 2021

Breast Cancer Trial in New Haven (Everolimus)

Terminated
Has Results
  • Breast Cancer
  • Everolimus
  • New Haven, Connecticut
    Yale University
Jan 12, 2022

Breast Cancer Trial in United States (ARV-471 in combination with Everolimus)

Not yet recruiting
  • Breast Cancer
  • ARV-471 in combination with Everolimus
  • San Diego, California
  • +4 more
Aug 12, 2022

Glioblastoma Multiforme, Glioma of Brain Trial in Chandler, Phoenix, Scottsdale (Ribociclib, Everolimus)

Active, not recruiting
  • Glioblastoma Multiforme
  • Glioma of Brain
  • Chandler, Arizona
  • +2 more
Mar 10, 2022

Breast Tumors, Endocrine Breast Diseases, Tumor Metastasis Trial in Baltimore (letrozole, lapatinib, everolimus)

Terminated
Has Results
  • Breast Neoplasms
  • +2 more
  • Baltimore, Maryland
    University of Maryland Marlene & Stewart Greenebaum Cancer Cente
Feb 9, 2022

Solid Organ Malignancies, Adenoidcystic Carcinoma, Neuroendocrine Tumors Trial in Atlanta (Lenalidomide, Everolimus)

Completed
Has Results
  • Solid Organ Malignancies
  • +2 more
  • Atlanta, Georgia
  • +1 more
Nov 19, 2021

Renal Cell Carcinoma Trial in Shanghai (Anlotinib HCl, everolimus)

Not yet recruiting
  • Renal Cell Carcinoma
  • Anlotinib hydrochloride
  • everolimus
  • Shanghai, China
    270 Dongan Road, Fudan University Shanghai Cancer Center
Nov 5, 2021

Renal Cell Carcinoma Trial (Cabozantinib, Ipilimumab, Nivolumab)

Not yet recruiting
  • Renal Cell Carcinoma
  • (no location specified)
Jun 9, 2022

Breast Cancer Trial in Birmingham (Letrozole, Everolimus, TRC105)

Active, not recruiting
  • Breast Cancer
  • Birmingham, Alabama
    University of Alabama at Birmingham
Jan 24, 2022

Uterine Sarcoma Trial (Everolimus)

Available
  • Uterine Sarcoma
  • Everolimus
  • (no location specified)
Jun 30, 2021

Differentiated Thyroid Cancer Trial in Philadelphia (Everolimus, Sorafenib)

Active, not recruiting
  • Differentiated Thyroid Cancer
  • Philadelphia, Pennsylvania
    Hospital of the University of Pennsylvania
Oct 18, 2021

Low Grade Glioma, World Health Organization (WHO) Grade II Astrocytomas, Oligodendrogliomas Trial in San Francisco (Everolimus,

Terminated
  • Low Grade Glioma
  • +3 more
  • San Francisco, California
    University of California, San Francisco
Nov 3, 2021

Neuroendocrine Tumors Trial in Boston, New York, Houston (LEE011, everolimus)

Active, not recruiting
  • Neuroendocrine Tumors
  • Boston, Massachusetts
  • +4 more
Feb 22, 2022

Stability of Tacrolimus, Cyclosporine A, Everolimus and

Recruiting
  • Transplantation Drugs Stability
  • Blood sampling
  • Turin, Italy
    AOU Città della Salute e della Scienza di Torino/S.C Biochimica
Mar 10, 2022

Everolimus-containing Chemotherapy in HER2- mBC PI3K/AKT/mTOR

Completed
  • Breast Cancer
  • +2 more
  • No intervention, it was a retrospective study.
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Sep 13, 2021

Pharmacokinetics Trial in Seoul (SVG101 (T), Afinitor (R))

Completed
  • Pharmacokinetics
  • SVG101 (T)
  • Afinitor (R)
  • Seoul, Korea, Republic of
    Yonsei University Healthcare System, Severance Hospital
Aug 3, 2022

Ischemic Heart Disease Trial in Seoul (Implanatation of Genoss DES sirolimus-eluting coronary system, Implanatation of Xience

Recruiting
  • Ischemic Heart Disease
  • Implanatation of Genoss DES sirolimus-eluting coronary system
  • Implanatation of Xience DES everolimus-eluting coronary system
  • Seoul, Korea, Republic of
    Cardiac and Vascular Center; Samsung Medical Center
Jun 29, 2022

Glioma, High Grade Glioma, Pontine Tumors Trial in Ann Arbor (Dasatinib, Everolimus)

Terminated
  • Glioma
  • +2 more
  • Ann Arbor, Michigan
    University of Michigan Cancer Center
Oct 12, 2021

Progeria Trial in Boston (Everolimus and lonafarnib)

Enrolling by invitation
  • Progeria
  • Everolimus and lonafarnib
  • Boston, Massachusetts
    Boston Children's Hospital
Jun 11, 2021